Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Breast Cancer Res Treat. 2011 Dec 3;132(1):215–223. doi: 10.1007/s10549-011-1889-0

Figure 3. Correlation between myeloid derived suppressor cell (MDSC) levels and pCR in study patients.

Figure 3

(A) FACS gating strategy for MDSCs. Circulating MDSC levels at baseline (B) and on cycle 1 day 8 (C), were significantly higher in patients who didn’t achieve a pCR after preoperative chemotherapy plus NOV-002